{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:02:41Z","timestamp":1785477761785,"version":"3.56.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670521"],"award-info":[{"award-number":["81670521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803798"],"award-info":[{"award-number":["81803798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.107920","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T22:54:00Z","timestamp":1625180040000},"page":"107920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["IL-6 downregulates hepatic carboxylesterases via NF-\u03baB activation in dextran sulfate sodium-induced colitis"],"prefix":"10.1016","volume":"99","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107920_b0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jnutbio.2015.10.006","article-title":"Preventive and therapeutic effects of blueberry (Vaccinium corymbosum) extract against DSS-induced ulcerative colitis by regulation of antioxidant and inflammatory mediators","volume":"28","author":"Pervin","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2021.107920_b0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cbi.2015.02.013","article-title":"Alterations of testosterone metabolism in microsomes from rats with experimental colitis induced by dextran sulfate sodium","volume":"232","author":"Huang","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2021.107920_b0015","doi-asserted-by":"crossref","first-page":"114260","DOI":"10.1016\/j.bcp.2020.114260","article-title":"\u03b2-patchoulene simultaneously ameliorated dextran sulfate sodium-induced colitis and secondary liver injury in mice via suppressing colonic leakage and flora imbalance","volume":"182","author":"Liu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107920_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard","year":"2014","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2021.107920_b0025","doi-asserted-by":"crossref","unstructured":"U. Navaneethan, Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk, 2, 2014, 193\u2013200.","DOI":"10.1093\/gastro\/gou036"},{"key":"10.1016\/j.intimp.2021.107920_b0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/liv.13265","article-title":"Hepatic manifestations of inflammatory bowel diseases","volume":"37","author":"Restellini","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2021.107920_b0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4254\/wjh.v9.i13.613","article-title":"Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease","volume":"9","author":"Tran-Minh","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.intimp.2021.107920_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejps.2013.12.019","article-title":"Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis","volume":"54","author":"Kusunoki","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2021.107920_b0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1248\/bpb.35.473","article-title":"Effect of lipopolysaccharide on the xenobiotic-induced expression and activity of hepatic cytochrome P450 in mice","volume":"35","author":"Moriya","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2021.107920_b0050","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.114.058065","article-title":"Inflammatory bowel disease alters intestinal bile acid transporter expression","volume":"42","author":"Jahnel","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2021.107920_b0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00003088-200140060-00006","article-title":"Pharmacokinetics of cyclosporin microemulsion in patients with inflammatory bowel disease","volume":"40","author":"Latteri","year":"2001","journal-title":"Clin. Pharmacokinet"},{"key":"10.1016\/j.intimp.2021.107920_b0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000237985","article-title":"Pharmacokinetics of metronidazole in patients with enteric disease compared to normal volunteers","volume":"27","author":"Bergan","year":"1981","journal-title":"Chemotherapy"},{"key":"10.1016\/j.intimp.2021.107920_b0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.apsb.2019.12.002","article-title":"Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model","volume":"10","author":"Fan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2021.107920_b0070","doi-asserted-by":"crossref","unstructured":"L. Lan, X. Ren, J. Yang, D. Liu, C. Zhang, Detection techniques of carboxylesterase activity: An update review, 94, 2020, 103388.","DOI":"10.1016\/j.bioorg.2019.103388"},{"key":"10.1016\/j.intimp.2021.107920_b0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cbi.2016.02.011","article-title":"Carboxylesterases: General detoxifying enzymes","volume":"259","author":"Hatfield","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2021.107920_b0080","doi-asserted-by":"crossref","unstructured":"J. Lian, R. Nelson, R. Lehner, Carboxylesterases in lipid metabolism: from mouse to human, 9, 2018, 178\u2013195.","DOI":"10.1007\/s13238-017-0437-z"},{"key":"10.1016\/j.intimp.2021.107920_b0085","doi-asserted-by":"crossref","unstructured":"Y. Li, M. Zalzala, K. Jadhav, Y. Xu, T. Kasumov, L. Yin, Y. Zhang, Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice, 63, 2016, 1860\u20131874.","DOI":"10.1002\/hep.28472"},{"key":"10.1016\/j.intimp.2021.107920_b0090","doi-asserted-by":"crossref","unstructured":"M.A. Ruby, J. Massart, D.M. Hunerdosse, M. Schonke, J.C. Correia, S.M. Louie, J.L. Ruas, E. Naslund, D.K. Nomura, J.R. Zierath, Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance, 18, 2017, 636\u2013646.","DOI":"10.1016\/j.celrep.2016.12.070"},{"key":"10.1016\/j.intimp.2021.107920_b0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2017.11.036","article-title":"17\u03b2-estradiol suppresses carboxylesterases by activating c-Jun\/AP-1 pathway in primary human and mouse hepatocytes","volume":"819","author":"Wu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107920_b0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13318-016-0326-5","article-title":"Regulations of Xenobiotics and Endobiotics on Carboxylesterases: A Comprehensive Review","volume":"41","author":"Xu","year":"2016","journal-title":"Eur. J. Drug Metab. Pharmacokinet"},{"key":"10.1016\/j.intimp.2021.107920_b0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1124\/dmd.117.077669","article-title":"A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms","volume":"45","author":"Wang","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2021.107920_b0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2021.107920_b0115","doi-asserted-by":"crossref","unstructured":"C.L. Zhang, S. Zhang, W.X. He, J.L. Lu, Y.J. Xu, J.Y. Yang, D. Liu, Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression. 186, 2017, 125\u2013132.","DOI":"10.1016\/j.lfs.2017.08.010"},{"key":"10.1016\/j.intimp.2021.107920_b0120","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2021.107920_b0125","doi-asserted-by":"crossref","unstructured":"X. Fan, X. Ding, Q.Y. Zhang, Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model, 10, 2020, 123\u2013135.","DOI":"10.1016\/j.apsb.2019.12.002"},{"key":"10.1016\/j.intimp.2021.107920_b0130","doi-asserted-by":"crossref","unstructured":"L.J. Dickmann, S.K. Patel, D.A. Rock, L.C. Wienkers, J.G. Slatter, Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture, 39, 2011, 1415\u20131422.","DOI":"10.1124\/dmd.111.038679"},{"key":"10.1016\/j.intimp.2021.107920_b0135","doi-asserted-by":"crossref","unstructured":"M.R. Chaluvadi, B.A. Nyagode, R.D. Kinloch, E.T. Morgan, TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease, 77, 2009, 464\u2013471.","DOI":"10.1016\/j.bcp.2008.10.029"},{"key":"10.1016\/j.intimp.2021.107920_b0140","doi-asserted-by":"crossref","unstructured":"J.L. Staudinger, C. Xu, Y.J. Cui, C.D. Klaassen, Nuclear receptor-mediated regulation of carboxylesterase expression and activity, 6, 2010, 261\u2013271.","DOI":"10.1517\/17425250903483215"},{"key":"10.1016\/j.intimp.2021.107920_b0145","doi-asserted-by":"crossref","unstructured":"X. Yang, X. Zhang, Y. Liu, T. Xi, J. Xiong, Insulin transcriptionally down-regulates carboxylesterases through pregnane X receptor in an Akt-dependent manner, 2019.","DOI":"10.1016\/j.tox.2019.04.008"},{"key":"10.1016\/j.intimp.2021.107920_b0150","doi-asserted-by":"crossref","unstructured":"E. Shan, Z. Zhu, S. He, D. Chu, D. Ge, Y. Zhan, W. Liu, J. Yang, J. Xiong, Involvement of pregnane X receptor in the suppression of carboxylesterases by metformin in vivo and in vitro, mediated by the activation of AMPK and JNK signaling pathway, 102, 2017, 14\u201323.","DOI":"10.1016\/j.ejps.2017.02.031"},{"key":"10.1016\/j.intimp.2021.107920_b0155","doi-asserted-by":"crossref","unstructured":"E.M. DeFilippis, S. Kumar, Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease, 60, 2015, 2873\u20132880.","DOI":"10.1007\/s10620-015-3699-4"},{"key":"10.1016\/j.intimp.2021.107920_b0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/1091581817735987","article-title":"Changes in the Pharmacokinetics of Phenytoin in Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice","volume":"36","author":"Kusunoki","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.intimp.2021.107920_b0165","doi-asserted-by":"crossref","unstructured":"Y. Yang, N. Hu, X.J. Gao, T. Li, Z.X. Yan, P.P. Wang, B. Wei, S. Li, Z.J. Zhang, S.L. Li, R. Yan Dextran Sulfate Sodium-induced Colitis and Ginseng Intervention Altered Oral Pharmacokinetics of Cyclosporine A in Rats, 2020, 113251.","DOI":"10.1016\/j.jep.2020.113251"},{"key":"10.1016\/j.intimp.2021.107920_b0170","doi-asserted-by":"crossref","unstructured":"S. Kawauchi, T. Nakamura, I. Miki, J. Inoue, T. Hamaguchi, T. Tanahashi, S. Mizuno, Downregulation of CYP3A and P-glycoprotein in the secondary inflammatory response of mice with dextran sulfate sodium-induced colitis and its contribution to cyclosporine A blood concentrations, 124, 2014, 180\u2013191.","DOI":"10.1254\/jphs.13141FP"},{"key":"10.1016\/j.intimp.2021.107920_b0175","doi-asserted-by":"crossref","unstructured":"Z. Merali, S. Ross, G. Pare, The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect, 29, 2014, 143\u2013151.","DOI":"10.1515\/dmdi-2014-0009"},{"key":"10.1016\/j.intimp.2021.107920_b0180","doi-asserted-by":"crossref","unstructured":"K. Achiwa, M. Ishigami, Y. Ishizu, T. Kuzuya, T. Honda, K. Hayashi, Y. Hirooka, Y. Katano, H. Goto, DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model, 470, 2016, 15\u201321.","DOI":"10.1016\/j.bbrc.2015.12.012"},{"key":"10.1016\/j.intimp.2021.107920_b0185","doi-asserted-by":"crossref","unstructured":"E. Gabele, K. Dostert, C. Hofmann, R. Wiest, J. Scholmerich, C. Hellerbrand, F. Obermeier, DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH, 55, 2011, 1391\u20131399.","DOI":"10.1016\/j.jhep.2011.02.035"},{"key":"10.1016\/j.intimp.2021.107920_b0190","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17425255.2017.1311323","article-title":"Inflammation and pharmacokinetics: potential implications for HIV-infection","volume":"13","author":"Seifert","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.intimp.2021.107920_b0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","article-title":"Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer","volume":"36","author":"Morgan","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2021.107920_b0200","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/dmd.108.026187","article-title":"Dual mechanisms of CYP3A protein regulation by pro-inflammatory cytokine stimulation in primary hepatocyte cultures","volume":"37","author":"Lee","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2021.107920_b0205","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/dmd.107.015511","article-title":"Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes","volume":"35","author":"Aitken","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2021.107920_b0210","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.xphs.2018.09.024","article-title":"Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis","volume":"108","author":"Erdmann","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2021.107920_b0215","doi-asserted-by":"crossref","unstructured":"R. Yamamoto, K. Muroi, H. Imaishi, Serum derived from ulcerative colitis mouse changes the metabolism of the fluorescent substrate by P450 depending on the degree of disease progression, 290, 2018, 88\u201398.","DOI":"10.1016\/j.cbi.2018.05.012"},{"key":"10.1016\/j.intimp.2021.107920_b0220","doi-asserted-by":"crossref","unstructured":"Y. Liu, J. Wu, L. Chen, X. Wu, Y. Gan, N. Xu, M. Li, H. Luo, F. Guan, Z. Su, J. Chen, Y. Li, Beta-patchoulene simultaneously ameliorated dextran sulfate sodium-induced colitis and secondary liver injury in mice via suppressing colonic leakage and flora imbalance, 182, 2020, 114260.","DOI":"10.1016\/j.bcp.2020.114260"},{"key":"10.1016\/j.intimp.2021.107920_b0225","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.intimp.2021.107920_b0230","doi-asserted-by":"crossref","unstructured":"F. Simon, J. Garcia, L. Guyot, J. Guitton, G. Vilchez, C. Bardel, M. Chenel, M. Tod, L. Payen, Impact of Interleukin-6 on Drug-Metabolizing Enzymes and Transporters in Intestinal Cells, 2019, 22, 16.","DOI":"10.1208\/s12248-019-0395-x"},{"key":"10.1016\/j.intimp.2021.107920_b0235","doi-asserted-by":"crossref","unstructured":"K.K. Machavaram, L.M. Almond, A. Rostami-Hodjegan, I. Gardner, M. Jamei, S. Tay, S. Wong, A. Joshi, J.R. Kenny, A physiologically based pharmacokinetic modeling approach to predict disease-drug interactions: suppression of CYP3A by IL-6, 94, 2013, 260\u2013268.","DOI":"10.1038\/clpt.2013.79"},{"key":"10.1016\/j.intimp.2021.107920_b0240","doi-asserted-by":"crossref","unstructured":"R. Ning, Y. Zhan, S. He, J. Hu, Z. Zhu, G. Hu, B. Yan, J. Yang, W. Liu, Interleukin-6 Induces DEC1, Promotes DEC1 Interaction with RXRalpha and Suppresses the Expression of PXR, CAR and Their Target Genes, 8, 2017, 866.","DOI":"10.3389\/fphar.2017.00866"},{"key":"10.1016\/j.intimp.2021.107920_b0245","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1096\/fj.02-0195fje","article-title":"Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved","volume":"16","author":"Jover","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2021.107920_b0250","doi-asserted-by":"crossref","unstructured":"J. Yang, C. Hao, D. Yang, D. Shi, X. Song, X. Luan, G. Hu, B. Yan, Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes, 197, 2010. 219\u2013226.","DOI":"10.1016\/j.toxlet.2010.06.003"},{"key":"10.1016\/j.intimp.2021.107920_b0255","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1124\/dmd.114.061317","article-title":"Establishment of a hepatocyte-kupffer cell coculture model for assessment of pro-inflammatory cytokine effects on metabolizing enzymes and drug transporters","volume":"43","author":"Nguyen","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2021.107920_b0260","doi-asserted-by":"crossref","unstructured":"B.A. Nyagode, C.M. Lee, E.T. Morgan, Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice, 335, 2010, 480\u2013488.","DOI":"10.1124\/jpet.110.171488"},{"key":"10.1016\/j.intimp.2021.107920_b0265","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/mol.107.036889","article-title":"Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2","volume":"72","author":"Yang","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107920_b0270","doi-asserted-by":"crossref","unstructured":"J. Xiong, W. Shang, L. Wu, R. Chen, W. Liu, R. Ning, G. Hu, J. Yang, Glucose dominates the regulation of carboxylesterases induced by lipopolysaccharide or interleukin-6 in primary mouse hepatocytes, 112, 2014, 41\u201348.","DOI":"10.1016\/j.lfs.2014.07.019"},{"key":"10.1016\/j.intimp.2021.107920_b0275","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1124\/dmd.112.048397","article-title":"Carboxylesterases are uniquely expressed among tissues and regulated by nuclear hormone receptors in the mouse","volume":"41","author":"Jones","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2021.107920_b0280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/17425250903483215","article-title":"Nuclear receptor-mediated regulation of carboxylesterase expression and activity","volume":"6","author":"Staudinger","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.intimp.2021.107920_b0285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2010.06.003","article-title":"Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes","volume":"197","author":"Yang","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.intimp.2021.107920_b0290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2010.08360.x","article-title":"Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers","volume":"152","author":"Richardson","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2021.107920_b0295","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2010.02.026","article-title":"Interleukin-6 in bone metastasis and cancer progression","volume":"46","author":"Ara","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.intimp.2021.107920_b0300","doi-asserted-by":"crossref","unstructured":"Y. Kusunoki, N. Ikarashi, Y. Hayakawa, M. Ishii, R. Kon, W. Ochiai, Y. Machida, K. Sugiyama, Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis, 54, 2014, 17\u201327.","DOI":"10.1016\/j.ejps.2013.12.019"},{"key":"10.1016\/j.intimp.2021.107920_b0305","doi-asserted-by":"crossref","unstructured":"Z. Mao, Y. Li, Y. Peng, X. Luan, H. Gui, X. Feng, G. Hu, J. Shen, B. Yan, J. Yang, Lipopolysaccharide down-regulates carbolesterases 1 and 2 and reduces hydrolysis activity in vitro and in vivo via p38MAPK-NF-kappaB pathway, 201, 2011, 213-20un.","DOI":"10.1016\/j.toxlet.2011.01.002"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:13:08Z","timestamp":1730837588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":61,"alternative-id":["S1567576921005567"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107920","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 downregulates hepatic carboxylesterases via NF-\u03baB activation in dextran sulfate sodium-induced colitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107920"}}